Pain Management Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Live Coverage of PAINWeek 2014

Exclusive access to live, onsite coverage of up-to-date evidence-based scientific findings in pain management.

IBD and Heavy Opioid Use

Clinicians should closely monitor the use of these medications in IBD treatment plans to reduce the risk of heavy subsequent use.

Pharmacies, Clinics Rx Drop-Off Sites

Attorney General Eric Holder stated that the new DEA regulation would help to prevent prescription drug misuse, particularly with opioid medications.

Aleve PM for Overnight Pain

Bayer HealthCare announced the launch of Aleve PM caplets for occasional sleeplessness associated with minor aches and pains.

Neck, Back Pain Improvement Factors

Observational registry-based research can inform patients and physicians about prognosis for subacute or chronic neck or low back pain.

Migraine Prophylactic Therapy

More research needs to be done to understand the reasons for non-adherence for migraine prophylactic therapy.

Pediatricians Prep for Anesthesia

Pediatricians have an important part in preparing surgical patients and their families for procedures, including anesthesia.

New Drug Product: Zubsolv

Maintenance treatment of opioid dependence, as part of a complete treatment plan to include counseling and psychosocial support.

News

Weight-Loss Surgery May Raise Risk of Severe Headaches

But experts find the study too small, problem too rare to be of concern.

Over 11,000 Boxes of Naproxen Recalled Due to Drug Mix-up

Contract Packaging Resources announced a voluntary recall of 11,640 boxes of Assured brand Naproxen Sodium Tablets due to some cartons containing bottles of Ibuprofen.

Do Anti-Inflammatory Drugs Have Antidepressant Effects?

Subgroups may benefit from anti-inflammatory treatment such as patients with elevated inflammatory markers or a somatic comorbidity.

Hospira Recalls Lidocaine HCl for Injection

Hospira announced a voluntary recall of 1% Lidocaine HCl for Injection after a confirmed report of human hair in a single unit.

First ER Morphine Designed to Deter Abuse When Crushed

The FDA has approved new labeling for Embeda (morphine sulfate and naltrexone HCl; Pfizer) extended-release (ER) capsules to include abuse-deterrence studies.

Featured courses from mycme

End-of-Life CareExternal web site

Discussing end-of-life issues and palliative care options with patients who have life-limiting illnesses is challenging. ...

CME|CE 1.25 Credits

Pitfalls in the Diagnosis and Treatment of Migraine HeadacheExternal web site

Migraine and other severe headaches are a common and major public health problem. Faculty presentations ...

CME 1.50 Credits

Pain Management Workshop (Pharmacology Credit)External web site

This program will discuss the causes of chronic pain as well as pharmacological options for ...

CE 3.00 Credits

Sign Up for Free e-newsletters